Coeliac disease: a histological follow-up study

Area of Science:

• Gastroenterology
• Immunology
• Pediatrics

Background:

• Coeliac disease (CD) diagnosis relies on standardized criteria, but follow-up lacks clear guidelines.
• Gluten-free diet (GFD) is the primary treatment for coeliac disease.
• Assessing histological response to GFD is crucial for long-term management.

Purpose of the Study:

• To evaluate the histological recovery of the duodenal mucosa in coeliac patients after adhering to a GFD.
• To identify factors influencing histological normalization in coeliac disease patients under GFD therapy.
• To compare the GFD's efficacy in achieving mucosal healing across different age groups.

Main Methods:

• Analysis of duodenal biopsy samples from 249 coeliac patients (165 female, 84 male) at diagnosis and after achieving clinical and biochemical remission on a GFD.
• Statistical evaluation of factors including age at diagnosis, sex, clinical presentation, time to follow-up biopsy, and Helicobacter pylori status.
• Comparison of histological normalization rates between paediatric and adult coeliac disease populations.

Main Results:

• All patients demonstrated mucosal improvement on a GFD.
• Complete histological normalization was achieved in 74.1% of paediatric patients versus 17.5% of adult patients.
• Age at diagnosis was a significant predictor of histological normalization (P < 0.0001), while sex, clinical picture, and time to follow-up were not.

Conclusions:

• Age at diagnosis is a critical factor in achieving complete histological remission in coeliac disease patients on a GFD.
• Current follow-up criteria for coeliac disease require better definition to ensure consistent study comparisons.
• Standardized reporting of remission criteria (clinical, biochemical, and histological) is recommended for coeliac disease research.